Detalhe da pesquisa
1.
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.
Ann Rheum Dis
; 80(3): 339-348, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168545
2.
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.
Ann Rheum Dis
; 76(9): 1550-1558, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473423
3.
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis.
Rheumatol Ther
; 10(3): 707-727, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869251
4.
Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study.
Ann Rheum Dis
; 70(11): 2003-7, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21914628
5.
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis.
Arthritis Rheum
; 62(6): 1792-802, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20191582
6.
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA.
Arthritis Res Ther
; 23(1): 245, 2021 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34537057
7.
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.
J Rheumatol
; 48(7): 1073-1081, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452173
8.
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure.
Lancet Rheumatol
; 3(8): e553-e562, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287621
9.
Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis.
Paediatr Drugs
; 22(6): 653-672, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029724
10.
Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept.
Pediatr Rheumatol Online J
; 18(1): 19, 2020 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087715
11.
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
Arthritis Rheumatol
; 70(7): 1144-1154, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481737
12.
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis.
Arthritis Care Res (Hoboken)
; 62(11): 1542-51, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20597110
13.
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine.
J Clin Psychiatry
; 69(7): 1046-56, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18605811